Efficacy of Daflon 500 mg in the Treatment of Lymphedema (Secondary to Conventional Therapy of Breast Cancer)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[alpha]-pyrone
1993 • 249 citations
The Lymphedema Chaos: A Lancet
1989 • 158 citations
A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility.
1993 • 52 citations
The pathophysiology of lymphedema and the action of benzo-pyrones in reducing it.
1988 • 37 citations
Lymphagogue and pulsatile activities of Daflon 500 mg on canine thoracic lymph duct.
1989 • 29 citations
Capillary filtration in idiopathic cyclic edema--effects of Daflon 500 mg.
1988 • 20 citations
Functional Study of the Limb Lymphatic System
1986 • 17 citations
Reduction of morbidity after radical mastectomy.
1981 • 11 citations
The Scintilymphangiographic ???Flare??? Sign of Lymphangitic Obstruction
1977 • 7 citations
Current Evaluation of Lymphoedema and Assessment by Lymphoscintigraphy of the Effect of a Micronized Flavonoid Fraction (Daflon 500 mg) in the Treatment of Upper Limb Lymphoedema
1994 • 3 citations